Kura Oncology, Inc. (KURA)
9.285
-0.24
(-2.57%)
USD |
NASDAQ |
Apr 23, 16:00
9.285
0.00 (0.00%)
After-Hours: 16:32
Kura Oncology EPS Diluted (Quarterly) : -0.9199 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.6165 |
| Lexicon Pharmaceuticals, Inc. | -0.0427 |
| Viemed Healthcare, Inc. | 0.1483 |
| Liquidia Corp. | 0.1455 |
| Agenus, Inc. | -0.301 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -81.00M |
| Revenue (Quarterly) | 17.34M |
| Total Expenses (Quarterly) | 98.34M |
| Enterprise Value | 195.00M |
| Gross Profit Margin (Quarterly) | 97.35% |
| Profit Margin (Quarterly) | -467.2% |
| Earnings Yield | -34.22% |
| Normalized Earnings Yield | -34.22 |